Loading stock data…
Roper Technologies (ROP)
$334.80-3.51 (-1.04%)
After Hours$334.80+0.00 (+0.00%)· Last close Jun 29
Roper Technologies, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Roper Technologies, Inc. in the Technology sector is trading at $334.80 with a market capitalization of $34.0B. Wall Street consensus targets $451.72 (15 analysts), implying a +34.9% move over the next 12 months. The stock is currently near its 52-week low of $305.96, remaining 16.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +34.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.10B↑ | $2.06B↑ | $2.02B↑ | $1.94B↑ | $1.88B |
| Gross Profit | $1.45B↑ | $1.43B↑ | $1.40B↑ | $1.35B↑ | $1.29B |
| Operating Income | $569.60M↓ | $588.30M↑ | $573.00M↑ | $548.30M↑ | $525.80M |
| Net Income | $508.90M↑ | $428.40M↑ | $398.50M↑ | $378.30M↑ | $331.10M |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Roper Technologies, Inc. designs and develops vertical software and technology enabled products in the United States, Canada, Europe, Asia, and internationally. Its Application Software segment offers comprehensive management, diagnostic and laborato...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$34.03B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.04%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.11%
Volume
Today's trading volume
755,790
Recent News
Roper Technologies Earnings Preview: What to Expect
Roper Technologies is gearing up to report its second-quarter earnings, with analysts anticipating single-digit bottom-line growth.
Roche (SWX:ROP) Wins Key Cancer Drug And Diagnostic FDA Milestones
Roche Holding received FDA acceptance of Lunsumio VELO plus Polivy for relapsed or refractory large B cell lymphoma based on phase III results. The FDA approved Roche's VENTANA PTEN assay as the first IHC test for identifying PTEN deficient prostate cancer. Tecentriq plus chemotherapy for stage III dMMR/MSI H colon cancer was granted FDA priority review following strong clinical trial data. These moves expand Roche's oncology and diagnostics portfolio and may influence treatment decisions...
Cinemark Holdings and 4 More Stocks Get Analyst Attention
Analysts also report on Boot Barn Holdings, Roper Technologies, Sphere Entertainment, and Hewlett Packard Enterprise.
Wall Street Analysts Believe Roper Technologies (ROP) Could Rally 36.61%: Here's is How to Trade
The mean of analysts' price targets for Roper Technologies (ROP) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Buy 5 Technology Laggards Despite the Sector's Dream Run in 2026
Despite XLK's 33.2% YTD surge, five tech laggards including PLTR, TEAM, TOST, U, and ROP show growth potential on AI and business momentum.